Detalhe da pesquisa
1.
Early response or nonresponse at week 2 and week 3 predict ultimate response or nonresponse in adolescents with schizophrenia treated with olanzapine: results from a 6-week randomized, placebo-controlled trial.
Eur Child Adolesc Psychiatry
; 24(12): 1485-96, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26032132
2.
Quetiapine versus aripiprazole in children and adolescents with psychosis--protocol for the randomised, blinded clinical Tolerability and Efficacy of Antipsychotics (TEA) trial.
BMC Psychiatry
; 14: 199, 2014 Jul 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-25015535
3.
Change and dispersion of QT interval during treatment with quetiapine extended release versus aripiprazole in children and adolescents with first-episode psychosis: results from the TEA trial.
Psychopharmacology (Berl)
; 235(3): 681-693, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29185022
4.
Quetiapine extended release versus aripiprazole in children and adolescents with first-episode psychosis: the multicentre, double-blind, randomised tolerability and efficacy of antipsychotics (TEA) trial.
Lancet Psychiatry
; 4(8): 605-618, 2017 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28599949
5.
Clinical Characteristics and Predictors of Outcome of Schizophrenia-Spectrum Psychosis in Children and Adolescents: A Systematic Review.
J Child Adolesc Psychopharmacol
; 26(5): 410-27, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-27136403